Home › Neutropenia › Massachusetts
Neutropenia clinical trials in Massachusetts
3 studies for Neutropenia are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Boston Children's Cancer Center, Boston
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 6, 2026 · NCT06056297Shwachman Diamond Syndrome Registry and Study
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
RecruitingObservational study
All ages · All sexes · Updated Apr 6, 2026 · NCT06056908Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
- Tufts Medical Center-Division of Geographic Medicine and Infectious Diseases, Boston
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Apr 10, 2025 · NCT05626530From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.